A recent study found that approximately 500,000 Australians regularly use glucagon-like peptide-1 (GLP-1) drugs, with nearly half of them paying between AU$200 and AU$700 per month out of pocket.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A recent study found that approximately 500,000 Australians regularly use glucagon-like peptide-1 (GLP-1) drugs, with nearly half of them paying between AU$200 and AU$700 per month out of pocket.